ResMed, Inc. (RMD) Misses Q2 EPS by 3c
ResMed, Inc. (NYSE: RMD) reported Q2 EPS of $0.60, $0.03 ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
